Neurogene Inc (NGNE)

EBITDA Margin

-8397.30%

TTM · Period ending:

NGNE logo

NGNE EBITDA Margin

Latest reported-8397.30%
NGNE TTM EBITDA Margin (-159.21% → -8397.30%)
High-resolution chart · PNG

NGNE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Neurogene Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-8,397.2973%
-7,771.3514%
-5,400.7568%
-4,788.6486%
-76.664%
-126.324%
-171.848%
-159.208%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.